5V4X
Human glucokinase in complex with novel pyrazole activator.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-02-17 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.98 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 48.874, 77.855, 119.927 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.080 |
R-factor | 0.1973 |
Rwork | 0.195 |
R-free | 0.25030 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.511 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | REFMAC |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 2.140 |
High resolution limit [Å] | 2.080 | 4.760 | 2.080 |
Rmerge | 0.076 | 0.042 | 0.443 |
Total number of observations | 151398 | ||
Number of reflections | 26923 | ||
<I/σ(I)> | 12.7 | ||
Completeness [%] | 95.5 | 99.7 | 66.9 |
Redundancy | 5.6 | 6.1 | 3.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277 | 15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K |